|
인쇄하기
취소
|
SMEDDS based Hepaphil boasts of better bioavailability
Published: 2004-02-27 06:57:00
Updated: 2004-02-27 06:57:00
KMS Company said that it has marketed Hepaphil soft capsule (biphenyl dimethyl dicarboxylate; BDD) to improve the dissolution rate of poorly water soluble drug using self-microemulsifying drug delivery system (SMEDDS), which was developed by local researchers of Pharmacy College, Sungkyunkwan University.
BDD is a synthetic analogue of schizandrin C, one of the components from Fructus shizand...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.